U-M scientist discover how viruses hide inside human cells

November 11, 1999

ANN ARBOR---What evil lurks in the hearts of cells? Erle Robertson and Murray Cotter know.

These University of Michigan scientists have discovered how some viruses can hide inside the nucleus of human cells for long periods of time---without producing symptoms or triggering an immune response---by attaching to host cell chromosomes. The virus survives by going dormant until a weakened immune system allows infected cells to begin multiplying wildly again.

In an article to be published in the Nov. 25, 1999, issue of Virology, Robertson and Cotter describe a series of experiments with Kaposi's sarcoma-associated herpesvirus or KSHV---a human virus associated with a type of cancer called Kaposi's sarcoma. In these studies, U-M scientists found a protein expressed by one gene on the virus that builds a biochemical docking station linking viral DNA to the chromosomes of lymphoma cells. The U-M study is the first to identify a specific tethering mechanism between a virus and its host cell.

KSHV, also known as human herpesvirus 8, is one of a family of gammaherpesviruses known to remain dormant in humans long after the initial infection is over. Other similar viruses include the Epstein-Barr virus, the human papilloma virus which causes cervical cancer, and viruses responsible for hepatitis B and hepatitis C.

"We've always suspected that latent viral DNA couldn't survive long term within cells without some type of tethering," said Robertson, Ph.D., assistant professor of microbiology and immunology in the U-M Medical School. "But the latency mechanism for these viruses has been a black box. Now we have a key that will get us in the front door."

Using cultures of lymphoma cells infected with KSHV, Cotter and Robertson identified a protein called the latency-associated nuclear antigen or LANA, which is expressed by one of approximately 80 genes encoded by the virus. They found that LANA binds to three regions of the KSHV genome, but is most likely to lock onto one specific region for tethering the virus to host chromosomes.

In addition to viral DNA, U-M scientists found that LANA also binds to histones---small proteins that link bundles of DNA called nucleosomes together to make chromatin fibers, which are folded and packed to form chromosomes.

"The results suggest a biochemical mechanism which binds elements of viral DNA to host chromosomes through the interaction of LANA, histone H1 and possibly other chromosomal proteins," Robertson said.

Robertson has evidence for a similar tethering mechanism in the Epstein-Barr virus, which infects immune system cells called B-lymphocytes. Associated with several varieties of cancer, including breast cancer, Epstein-Barr virus is found in more than 90 percent of the world's population. In most people, a healthy immune system keeps the virus suppressed. If something upsets the balance between virus and immune response, however, the virus can re-activate. The trigger that signals a dormant virus to begin multiplying and infecting new cells remains unknown, according to Robertson.

In previous studies with Epstein-Barr virus, scientists identified a protein called EBNA1, which binds to B-lymphocyte chromosomes. Since ENBA1 is expressed in all EBV-infected cells and LANA is expressed in all KSHV-infected cells, Robertson believes they may have similar functions. "We haven't linked all the pieces yet, but it is extremely likely that EBNA1 is part of a similar tethering mechanism for Epstein-Barr viral DNA," he said. "If there are two viruses with the same mechanism, then there probably are more."

HIV, the virus that causes AIDS, is a different type of virus and is unrelated to the U-M study, adds Robertson. However, Kaposi's sarcoma is a common cancer in people whose immune system has been suppressed by the AIDS virus.

In future research, U-M scientists will try to find LANA's exact binding site on Kaposi's viral DNA and on histone proteins. "Once we understand the biochemistry of the tethering site, we can start developing therapeutic agents to block it. Blocking the binding site could mean the difference between just treating symptoms and eradicating these viruses from the host population," added Murray A. Cotter II, a graduate student in the U-M Medical School.

Cotter also hopes to apply what he learns from KSHV biology to gene therapy research. "The central question in gene therapy is how do you stabilize foreign genes in a cell's nucleus, so they will express beneficial proteins over long periods of time," he said. "This tethering mechanism may give us clues that we could use to develop more effective gene therapy vectors."

The U-M has applied for a patent on the viral tethering mechanism. The research was supported by the National Cancer Institute, the American Heart Association, the Leukemia Society of America, and the U-M Health System's Comprehensive Cancer Center.
-end-


University of Michigan

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.